-
Macquarie Turns Bullish On Kimberly Clark: 'We Are More Confident In The Sales Growth Outlook'
Tuesday, April 23, 2019 - 3:06pm | 408Read More...Kimberly Clark Corp (NYSE: KMB) received an upgrade Tuesday from Macquarie on the basis of a stronger earnings outlook. The Analyst Caroline Levy upgraded Kimberly Clark from Neutral to Outperform and raised the price target from $102 to $142. The Thesis Kimberly Clark’s price...
-
Beverage Stocks: Macquarie Bullish On Diageo, Pepsi, But Says Constellation's Asset Sale Was Underpriced
Thursday, April 18, 2019 - 1:09pm | 427Read More...It’s been a mixed bag for beverage investors in recent quarters, but one analyst reiterated coverage of three beverage names on Thursday and said there’s an excellent buying opportunity for selective investors. The Analyst Macquarie analyst Caroline Levy has the following coverage:...
-
Analyst: Constellation's Wine Sale Will Likely Be Dilutive For 3 Years
Thursday, April 4, 2019 - 12:16pm | 373Read More...Alcohol company Constellation Brands, Inc. (NYSE: STZ) reached an agreement Wednesday to sell around 30 brands from its wine and spirits portfolio. What Happened Constellation Brands, perhaps best known for its Corona beer, will divest more than two dozen brands that retail for $11 and below,...
-
Mixing It Up: Keurig Dr. Pepper, Anheuser-Busch Expanding K-Cup Cocktail Effort
Tuesday, March 19, 2019 - 4:31pm | 536Read More...How’s this for a mixed drink idea? Take one beer maker with sluggish sales looking to broaden its product offerings. Stir in a coffee and soda company hoping to shake things up. Add liquor. Keurig Dr. Pepper Inc (NYSE: KDP) and Anheuser Busch InBev NV (NYSE: BUD) are trying to concoct some...
-
Analysts: Estée Lauder's Strength Isn't Just Cosmetic
Thursday, March 7, 2019 - 12:39pm | 577Read More...Estée Lauder Companies (NYSE: EL) put on its best face at its Wednesday investor day in New York, and several analysts said they remain impressed with the company’s strong foundation. Investors have already accounted for much of the iconic cosmetic company's strength, though,...
-
Monster Beverage Posts Sales, EPS Beat: 4 Sell-Side Takes
Thursday, February 28, 2019 - 12:42pm | 600Read More...The market woke up Thursday to energetic interest in Monster Beverage Corporation (NASDAQ: MNST), which was surging after posting better-than-expected top-line results. Monster reported 15.8-percent organic sales growth in the fourth quarter, and its earnings per share of 43 cents beat...
-
Procter & Gamble's CAGNY Presentation Turns Macquarie Incrementally Bullish
Tuesday, February 26, 2019 - 5:07pm | 416Read More...Consumer products giant Procter & Gamble Co (NYSE: PG)'s presentation last week at the Consumer Analyst Group of New York conference prompted Macquarie Research to become incrementally bullish on the stock. The Analyst Analyst Caroline Levy maintained an Outperform rating on...
-
'They've Got To Diversify': Anheuser-Busch Buys Liquor, Canned Cocktail Company Cutwater
Tuesday, February 26, 2019 - 11:48am | 764Read More...Your dad's domestic beer is getting a little flat. At least in terms of sales. A flatter and flatter growth curve has traditional domestic beermakers looking for other drinks they can sling — and the purchase of a fast-growing liquor company by the world's largest beer maker may be...
-
Macquarie Raises A Glass To Boston Beer, Upgrades After Q4 EPS Beat
Thursday, February 21, 2019 - 11:27am | 420Read More...Boston Beer Company Inc (NYSE: SAM) is toasting a fourth-quarter bottom-line beat despite a top-line miss. The acheivement led one bear on the Street to upgrade the stock. The Analyst Macquarie Research analyst Caroline Levy upgraded Boston Beer from Underperform to Neutral and...
-
Macquarie Remains Cautious On Constellation Ahead Of Cannabis-Related Losses
Thursday, February 21, 2019 - 10:01am | 401Read More...Some on the Street saw wisdom in Constellation Brands, Inc. (NYSE: STZ)'s cannabis play. But on Wednesday, when management guided for a 10-cent quarterly earnings hit from its Canopy Growth Corp. (NYSE: CGC) investment, investors second-guessed the strategy. The Rating Macquarie Research...
-
Why Macquarie Prefers Pepsi Over Coca-Cola
Tuesday, February 19, 2019 - 4:11pm | 377Read More...PepsiCo, Inc. (NASDAQ: PEP), under the leadership of new CEO Ramon Laguarta, is well-positioned to deliver sustainable 4-6-percent sales growth, according to Macquarie. The Analyst Analyst Caroline Levy upgraded PepsiCo from Neutral to Outperform with a price target lifted from $107 to $126....
-
Estee Lauder: Analysts Mostly Bullish On Q2 Results, Despite Weak Guidance
Wednesday, February 6, 2019 - 4:57pm | 513Read More...Estee Lauder Companies Inc (NYSE: EL) is having a strong week after reporting a second-quarter earnings beat Tuesday. The Sell-Side Reacts ◘ Although the company reported weak third-quarter and 2019 earnings guidance, Raymond James analyst Joseph Altobello reiterated an Outperform rating...
-
The Alcohol Market's Changing Chemistry: Younger, Healthier Drinkers Want Options
Tuesday, February 5, 2019 - 9:30am | 559Read More...Younger alcohol drinkers are more health-conscious and want less sugar, alcohol and calories in their brews. At the same time, they want more choices, including hard seltzer waters and no-calorie beverages. These were some of the key takeaways for Macquarie Research from Harry Schuhmacher’s...
-
Analysts Like Procter And Gamble Sales Numbers, Dislike Margins
Thursday, January 24, 2019 - 5:15pm | 412Read More...Procter and Gamble Co (NYSE: PG) stock was down Thursday but analysts reactions were mixed after an earnings report that saw better-than expected sales growth offset by disappointing margins. The Analysts Raymond James analyst Joseph Altobello maintained a Market Perform rating on Procter and...
-
Macquarie: Coca-Cola European Partners Faces Downside Risk From UK Plastic Regulations
Wednesday, January 2, 2019 - 12:49pm | 343Read More...The UK recently proposed that producers of plastic items should pay 100 percent of disposal costs versus the 10 percent being paid now. This represents downside risk to earnings at Coca-Cola European Partners PLC (NYSE: CCEP), although the impact can be estimated only after there are more...
